William R. Greco

5.6k total citations · 1 hit paper
82 papers, 4.5k citations indexed

About

William R. Greco is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, William R. Greco has authored 82 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 22 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in William R. Greco's work include Drug Transport and Resistance Mechanisms (11 papers), Photodynamic Therapy Research Studies (11 papers) and Nanoplatforms for cancer theranostics (8 papers). William R. Greco is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Photodynamic Therapy Research Studies (11 papers) and Nanoplatforms for cancer theranostics (8 papers). William R. Greco collaborates with scholars based in United States, France and Germany. William R. Greco's co-authors include Giangiacomo Bravo, Youcef M. Rustum, David A. Bellnier, Harry K. Slocum, Lurine A. Vaughan, Barbara W. Henderson, Thomas J. Dougherty, Allan R. Oseroff, Maire Hakala and Oskar S. Frankfurt and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

William R. Greco

82 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The search for synergy: a critical review from a response surface perspective.

1995 1.1k citations William R. Greco, Giangiacomo Bravo et al. Pharmacological Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William R. Greco United States	32	1.4k	1.2k	1.1k	840	579	82	4.5k
M. C. Berenbaum United Kingdom	33	1.7k 1.2×	1.5k 1.3×	748 0.7×	965 1.1×	443 0.8×	100	6.1k
James M. Gallo United States	42	1.9k 1.4×	432 0.4×	1.3k 1.2×	535 0.6×	517 0.9×	154	5.0k
Thomas Meyer Switzerland	45	3.7k 2.6×	887 0.8×	2.2k 2.0×	185 0.2×	668 1.2×	137	7.9k
Amit K. Tiwari United States	40	3.1k 2.2×	501 0.4×	2.1k 1.9×	373 0.4×	643 1.1×	215	6.5k
Peter J. Bugelski United States	39	1.7k 1.2×	563 0.5×	780 0.7×	283 0.3×	353 0.6×	137	5.2k
Melinda G. Hollingshead United States	45	3.9k 2.8×	533 0.5×	1.9k 1.7×	345 0.4×	1.2k 2.1×	167	6.9k
Joseph Ciccolini France	36	1.6k 1.2×	683 0.6×	2.4k 2.2×	411 0.5×	677 1.2×	196	4.5k
Marián Hajdúch Czechia	51	5.6k 4.0×	880 0.8×	1.6k 1.5×	610 0.7×	1.5k 2.5×	422	10.7k
N. Leigh Anderson United States	45	7.5k 5.3×	519 0.4×	646 0.6×	1.2k 1.4×	549 0.9×	97	11.4k
Saijun Fan China	50	4.7k 3.3×	939 0.8×	1.7k 1.5×	780 0.9×	1.0k 1.8×	173	8.6k

Countries citing papers authored by William R. Greco

Since Specialization

Citations

This map shows the geographic impact of William R. Greco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William R. Greco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William R. Greco more than expected).

Fields of papers citing papers by William R. Greco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William R. Greco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William R. Greco. The network helps show where William R. Greco may publish in the future.

Co-authorship network of co-authors of William R. Greco

This figure shows the co-authorship network connecting the top 25 collaborators of William R. Greco. A scholar is included among the top collaborators of William R. Greco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William R. Greco. William R. Greco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krzyżański, Wojciech, et al.. (2009). D-optimal designs for parameter estimation for indirect pharmacodynamic response models. Journal of Pharmacokinetics and Pharmacodynamics. 36(6). 523–539. 7 indexed citations

Pawarode, Attaphol, Hans Minderman, Kieran L. O’Loughlin, William R. Greco, & Maria R. Baer. (2006). Rapamycin overcomes multidrug resistance (MDR) mediated by P-glycoprotein (Pgp), Multidrug Resistance Protein-1 (MRP-1), Breast Cancer Resistance Protein (BCRP) and Lung Resistance Protein (LRP) and synergizes with substrate drugs in MDR cells.. Cancer Research. 66. 1270–1270. 3 indexed citations

Hector, Suzanne, William R. Greco, Kimberly Clark, et al.. (2006). Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells. Cancer Chemotherapy and Pharmacology. 59(6). 711–723. 21 indexed citations

Leichman, Lawrence, David Lawrence, Cynthia G. Leichman, et al.. (2006). Expression of Genes Related to Activity of Oxaliplatin and 5-Fluorouracil in Endoscopic Biopsies of Primary Esophageal Cancer in Patients Receiving Oxaliplatin, 5-Flourouracil and Radiation: Characterization and Exploratory Analysis with Survival. Journal of Chemotherapy. 18(5). 514–524. 12 indexed citations

Kau, Yi‐Chuan, Antonella Zizza, David Zurakowski, et al.. (2006). Efficacy of Lidocaine or Bupivacaine Combined With Ephedrine in Rat Sciatic Nerve Block. Regional Anesthesia & Pain Medicine. 31(1). 14–18. 28 indexed citations

Bellnier, David A., William R. Greco, Gregory Loewen, et al.. (2006). Clinical Pharmacokinetics of the PDT Photosensitizers Porfimer Sodium (Photofrin), 2‐[1‐Hexyloxyethyl]‐2‐Devinyl Pyropheophorbide‐a (Photochlor) and 5‐ALA‐Induced Protoporphyrin IX. Lasers in Surgery and Medicine. 38(5). 439–444. 75 indexed citations

Bellnier, David A., William R. Greco, Hector Nava, et al.. (2005). Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy. Cancer Chemotherapy and Pharmacology. 57(1). 40–45. 88 indexed citations

Minderman, Hans, Kieran L. O’Loughlin, Patrick F. Smith, et al.. (2005). Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia. Cancer Chemotherapy and Pharmacology. 57(1). 73–83. 6 indexed citations

Suvannasankha, Attaya, Hans Minderman, Kieran L. O’Loughlin, et al.. (2004). Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease‐free survival. British Journal of Haematology. 127(4). 392–398. 48 indexed citations

10.

Bellnier, David A., William R. Greco, Gregory Loewen, et al.. (2003). Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.. PubMed. 63(8). 1806–13. 112 indexed citations

11.

White, Donald B., et al.. (2003). A New Nonlinear Mixture Response Surface Paradigm for the Study of Synergism: A Three Drug Example. Current Drug Metabolism. 4(5). 399–409. 39 indexed citations

12.

Suvannasankha, Attaya, Hans Minderman, Kieran L. O’Loughlin, et al.. (2003). Expression of the neural cell adhesion molecule CD56 is not associated with P-glycoprotein overexpression in core-binding factor acute myeloid leukemia. Leukemia Research. 28(5). 449–455. 3 indexed citations

13.

Ojima, Iwao, Jean Veith, Paula Pera, et al.. (2001). Effects of Orally Active Taxanes on P-Glycoprotein Modulation and Colon and Breast Carcinoma Drug Resistance. JNCI Journal of the National Cancer Institute. 93(16). 1234–1245. 74 indexed citations

14.

Wang, Henry Z., et al.. (2001). Brain MR Imaging in the Evaluation of Chronic Headache in Patients without Other Neurologic Symptoms. Academic Radiology. 8(5). 405–408. 55 indexed citations

15.

Henderson, Barbara W., Theresa M. Busch, Lurine A. Vaughan, et al.. (2000). Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate.. PubMed. 60(3). 525–9. 228 indexed citations

16.

Slocum, Harry K., John Carmi Parsons, Lori Broderick, et al.. (2000). Time-lapse video reveals immediate heterogeneity and heritable damage among human ileocecal carcinoma HCT-8 cells treated with raltitrexed (ZD1694). Cytometry. 41(4). 252–260. 5 indexed citations

17.

Faessel, Hélène M., et al.. (1999). Folic acid-enhanced synergy for the combination of trimetrexate plus the glycinamide ribonucleotide formyltransferase inhibitor 4-[2-(2-Amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimidino[5,4,6][1,4]thiazin-6-yl)-(S)-ethyl]-2,5-thienoylamino-l-glutamic acid (AG2034). Biochemical Pharmacology. 57(5). 567–577. 11 indexed citations

18.

Greco, William R., et al.. (1997). Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells. Cancer Chemotherapy and Pharmacology. 40(6). 495–505. 28 indexed citations

19.

Greco, William R., et al.. (1995). The search for synergy: a critical review from a response surface perspective.. Pharmacological Reviews. 47(2). 331–385. 1144 indexed citations breakdown →

20.

Greco, William R. & Youcef M. Rustum. (1992). Correspondence re: W. R. Greco et al., Application of a New Approach for the Quantitation of Drug Synergism to the Combination of cis-Diamminedichloroplatinum and 1-β-d-Arabinofuranosylcytosine. Cancer Res., 50: 5318–5327, 1990.—Reply. Cancer Research. 52(16). 4561–4565. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact